Healthcare -
Biotechnology - NASDAQ - US
$ 0.5008
-4.32 %
$ 61.9 M
Market Cap
-0.83
P/E
MRSN - OPERATING EXPENSES
Operating Expenses MRSN - Mersana Therapeutics, Inc.
36.9 M
LAST VALUE
-53.29%
2 YEAR CAGR
-13.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR